Outer Membrane Vesicle‐Coated Nanoparticle Vaccine Protects against Acinetobacter baumannii Pneumonia and Sepsis
Advanced NanoBiomed Research · 2023-02 · 3 (2)
DOI: 10.1002/anbr.202200130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced NanoBiomed Research, online erschienen am 22.12.2022. Verfasst von Elisabet Bjanes und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, California 92093, USA. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, A.P. Giannini Foundation.
Themen: Sepsis
Abstract (Originalsprache)
The highly multidrug‐resistant (MDR) Gram‐negative bacterial pathogen Acinetobacter baumannii is a top global health priority where an effective vaccine can protect susceptible populations and limit resistance acquisition. Outer membrane vesicles (OMVs) shed from Gram‐negative bacteria are enriched with virulence factors and membrane lipids but heterogeneous in size and cargo. Herein, a vaccine platform combining precise and replicable nanoparticle technology with immunogenic A. baumannii OMVs (Ab‐OMVs) is reported. Gold nanoparticle cores coated with Ab‐OMVs (Ab‐NPs) induce robust IgG titers in rabbits that enhance human neutrophil opsonophagocytic killing and passively protect against lethal A. baumannii sepsis in mice. Active Ab‐NP immunization in mice protects against sepsis and pneumonia, accompanied by B cell recruitment to draining lymph nodes, activation of dendritic cell markers, improved splenic neutrophil responses, and mitigation of proinflammatory cytokine storm. Nanoparticles are an efficient and efficacious platform for OMV vaccine delivery against A. baumannii and perhaps other high‐priority MDR pathogens.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, California 92093, USA.
- Department of Nanoengineering, University of California San Diego, La Jolla, California 92093, USA.
- School of Biotechnology, Amrita Vishwa Vidyapeetham, Amritapuri, Kerala, India.
- Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California 92093, USA.
ORCID-Profile: Liangfang Zhang, Victor Nizet
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- A.P. Giannini Foundation
- Defense Threat Reduction Agency
Zitieren
APA
Bjanes, E., Zhou, J., Qayum, T., Krishnan, N., Zurich, R. H., Menon, N. D., Hoffman, A., Fang, R. H., Zhang, L., & Nizet, V. (2023). Outer Membrane Vesicle‐Coated Nanoparticle Vaccine Protects against Acinetobacter baumannii Pneumonia and Sepsis. Advanced NanoBiomed Research, 3(2). https://doi.org/10.1002/anbr.202200130
Vancouver
Bjanes E, Zhou J, Qayum T, Krishnan N, Zurich RH, Menon ND, et al. Outer Membrane Vesicle‐Coated Nanoparticle Vaccine Protects against Acinetobacter baumannii Pneumonia and Sepsis. Advanced NanoBiomed Research. 2023;3(2). doi:10.1002/anbr.202200130
BibTeX
@article{Bjanes2023,
author = {Bjanes, Elisabet and Zhou, Jiarong and Qayum, Tariq and Krishnan, Nishta and Zurich, Raymond H and Menon, Nitasha D and Hoffman, Alexandria and Fang, Ronnie H and Zhang, Liangfang and Nizet, Victor},
title = {Outer Membrane Vesicle‐Coated Nanoparticle Vaccine Protects against Acinetobacter baumannii Pneumonia and Sepsis},
journal = {Advanced NanoBiomed Research},
year = {2023},
volume = {3},
number = {2},
doi = {10.1002/anbr.202200130}
}
EUVIMED